Home › NDC Lookup › Labelers › Janssen Biotech, Inc.

Janssen Biotech, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 57894 (Janssen Biotech, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

64
Package NDCs
64
Products
64
Active listings
0
Discontinued
17
Ingredients
0
Therapeutic classes
9
Dosage forms
10
With NADAC pricing

Portfolio

Top ingredients
ustekinumab 21
AMIVANTAMAB and HYALURONIDASE-lpuj... 8
nipocalimab-aahu 4
Daratumumab 4
golimumab 3
ciltacabtagene autoleucel 3
Guselkumab 3
INFLIXIMAB 2
lazertinib 2
teclistamab-cqyv 2
By dosage form
INJECTION 19
INJECTION, SOLUTION 16
SOLUTION 8
INJECTION, SOLUTION, CONCENTRATE 8
TABLET, FILM COATED 6
INJECTION, SUSPENSION 3
INJECTION, POWDER, LYOPHILIZED, FO... 2
TABLET 1

Browse records — 64 products

Drug / product Billing NDC NADAC / unit Status
AKEEGA NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE 50 mg/1; 500 mg/1 TABLET, FILM COATED Janssen · NDC 57894-0050-60 · 1 BOTTLE in 1 CARTON (57894-050-60) / 60 TABLET, FILM COATED in 1 BOTTLE 57894-0050-60 — On market View →
AKEEGA NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE 100 mg/1; 500 mg/1 TABLET, FILM COATED Janssen · NDC 57894-0100-60 · 1 BOTTLE in 1 CARTON (57894-100-60) / 60 TABLET, FILM COATED in 1 BOTTLE 57894-0100-60 — On market View →
CARVYKTI ciltacabtagene autoleucel 100000000 1/1 INJECTION, SUSPENSION Janssen · NDC 57894-0111-01 · Q2056 · 1 INJECTION, SUSPENSION in 1 BAG (57894-111-01) 57894-0111-01 — On market View →
CARVYKTI ciltacabtagene autoleucel 100000000 1/1 INJECTION, SUSPENSION Janssen · NDC 57894-0111-01 · Q2056 · 1 INJECTION, SUSPENSION in 1 BAG (57894-111-01) 57894-0111-01 — On market View →
CARVYKTI ciltacabtagene autoleucel 100000000 1/1 INJECTION, SUSPENSION Janssen · NDC 57894-0111-01 · Q2056 · 1 INJECTION, SUSPENSION in 1 BAG (57894-111-01) 57894-0111-01 — On market View →
DARZALEX Daratumumab 100 mg/5mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0502-05 · 1 VIAL in 1 CARTON (57894-502-05) / 5 mL in 1 VIAL 57894-0502-05 — Discontinued View →
DARZALEX Daratumumab 100 mg/5mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0502-05 · 1 VIAL in 1 CARTON (57894-502-05) / 5 mL in 1 VIAL 57894-0502-05 — Discontinued View →
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION Janssen · NDC 57894-0503-01 · J9144 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0503-01 — On market View →
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION Janssen · NDC 57894-0503-01 · J9144 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0503-01 — On market View →
Darzalex IV Daratumumab 100 mg/5mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0505-05 · J9145 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE 57894-0505-05 — On market View →
Darzalex IV Daratumumab 100 mg/5mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0505-05 · J9145 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE 57894-0505-05 — On market View →
ICOTYDE icotrokinra 200 mg/1 TABLET, FILM COATED Janssen · NDC 57894-0201-07 · 1 BLISTER PACK in 1 CARTON (57894-201-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK (57894-201-01) 57894-0201-07 — On market View →
IMAAVY nipocalimab-aahu 185 mg/mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0800-01 · J9256 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-800-01) / 1.62 mL in 1 VIAL, SINGLE-DOSE 57894-0800-01 — On market View →
IMAAVY nipocalimab-aahu 185 mg/mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0801-01 · J9256 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-801-01) / 6.5 mL in 1 VIAL, SINGLE-DOSE 57894-0801-01 — On market View →
IMAAVY nipocalimab-aahu 185 mg/mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0801-01 · J9256 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-801-01) / 6.5 mL in 1 VIAL, SINGLE-DOSE 57894-0801-01 — On market View →
IMAAVY nipocalimab-aahu 185 mg/mL INJECTION, SOLUTION, CONCENTRATE Janssen · NDC 57894-0800-01 · J9256 · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-800-01) / 1.62 mL in 1 VIAL, SINGLE-DOSE 57894-0800-01 — On market View →
INFLIXIMAB 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Janssen · NDC 57894-0160-01 · J1745 · 1 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIAL, SINGLE-USE 57894-0160-01 — On market View →
INLEXZO gemcitabine intravesical 225 mg/1 SYSTEM Janssen · NDC 57894-0225-01 · J9183 · 1 SYSTEM in 1 BOX (57894-225-01) 57894-0225-01 — On market View →
LAZCLUZE lazertinib 80 mg/1 TABLET, FILM COATED Janssen · NDC 57894-0080-60 · 1 BOTTLE in 1 CARTON (57894-080-60) / 60 TABLET, FILM COATED in 1 BOTTLE 57894-0080-60 — On market View →
LAZCLUZE lazertinib 240 mg/1 TABLET, FILM COATED Janssen · NDC 57894-0240-30 · 1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE 57894-0240-30 — On market View →
REMICADE INFLIXIMAB 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Janssen · NDC 57894-0030-01 · J1745 · 1 VIAL, SINGLE-USE in 1 BOX (57894-030-01) / 10 mL in 1 VIAL, SINGLE-USE 57894-0030-01 $1,135.970 /unit · NADAC On market View →
Rybrevant amivantamab-vmjw 350 mg/1 INJECTION Janssen · NDC 57894-0501-01 · J9061 · 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00) 57894-0501-01 — On market View →
Rybrevant amivantamab-vmjw 350 mg/1 INJECTION Janssen · NDC 57894-0501-01 · J9061 · 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00) 57894-0501-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION Janssen · NDC 57894-0515-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0515-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 3520 mg/22mL; 44000 mg/22mL INJECTION Janssen · NDC 57894-0522-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01) / 22 mL in 1 VIAL, SINGLE-DOSE 57894-0522-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 1600 mg/10mL; 20000 mg/10mL INJECTION Janssen · NDC 57894-0510-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE 57894-0510-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2240 mg/14mL; 28000 mg/14mL INJECTION Janssen · NDC 57894-0514-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE 57894-0514-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 3520 mg/22mL; 44000 mg/22mL INJECTION Janssen · NDC 57894-0522-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01) / 22 mL in 1 VIAL, SINGLE-DOSE 57894-0522-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION Janssen · NDC 57894-0515-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0515-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2240 mg/14mL; 28000 mg/14mL INJECTION Janssen · NDC 57894-0514-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE 57894-0514-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.